E V Privalova - Sechenov Moscow State Med Univ, Sechenov Univ

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 81 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term Effects of Enhanced External Counterpulsation in the Management of Patients with Ischemic Chronic Heart Failure

A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, M. F. Petruhnova,E. V. Privalova,Yu. N. Belenkov

RATIONAL PHARMACOTHERAPY IN CARDIOLOGYno. 2 (2024)

引用0浏览0引用

INFLUENCE OF REMOTE DIGITAL OBSERVATIONS ON QUALITY OF LIFE, COMPLIANCE, AND CLINICAL OUTCOMES IN PATIENTS WITH CHRONIC HEART FAILURE

A. V. Emel’yanov,E. A. Zheleznykh,M. V. Kozhevnikova,V. Yu. Zektser, A. É. Kamalova,E. V. Privalova,Yu. N. Belenkov

BIOMEDICAL ENGINEERINGno. 5 (2024): 311-315

引用0浏览0引用

WNT Signaling Cascade Proteins and LRP6 in the Formation of Various Types of Coronary Lesions in Patients with Coronary Artery Disease

Yu . N. Belenkov,A. O. Iusupova,O. A. Slepova,N. N. Pakhtusov,L. V. Popova,A. S. Lishuta,A. V. Krivova,N. V. Khabarova, M. Abidaev Yu,E. V. Privalova

KARDIOLOGIYAno. 5 (2024)

引用0浏览0WOS引用

Effectiveness of different treatment regimens of enhanced external counterpulsation in patients with stable coronary artery disease complicated by heart failure

A. S. Lishuta,O. A. Slepova,N. A. Nikolaeva,N. V. Khabarova,E. V. Privalova,Yu. N. Belenkov

Рациональная фармакотерапия в кардиологии（2024）

引用0浏览0引用

Study of the Initial Vasculotoxic Risk in Patients with Lymphoproliferative Diseases Before the Start of Polychemotherapy

R. R. Karimov,E. Yu. Salakheeva,D. A. Budanova,O. N. Antyufeeva,O. V. Bochkarnikova,E. V. Privalova,Yu. N. Belenkov,I. S. Ilgisonis

Clinical Medicine (Russian Journal)no. 1 (2024): 48-56

引用0浏览0引用

Correlation Between the Level of C-reactive Protein and the Parameters of the Functional Status of the Left Atrium in Patients with Lymphoproliferative Diseases Against the Background of Chemotherapy

E. Yu. Salakheeva,A. A. Shchendrygina,I. Ya. Sokolova,K. A. Zhbanov,S. A. Tsatsurova, N. I. Kanevskiy, Yu. N. Muzychenko,S. A. Kardanova, V. O. Stebakova,E. V. Privalova,T. Yu. Kulagina, O. A. Bulkina,I. S. Ilgisonis,Yu. N. Belenkov

Clinical Medicine (Russian Journal)no. 1 (2023): 55-62

引用0浏览0引用

Plasma Branched-Chain Amino Acid Concentrations in Individuals Without Cardiovascular Diseases Versus Patients Diagnosed with Hypertension and Coronary Artery Disease

M. V. Kozhevnikova,E. O. Korobkova,A. V. Krivova,A. V. Kukharenko,N. E. Moskaleva,K. M. Shestakova,N. V. Mesonzhnik,A. A. Ageev, A. A. Boldin, A. Brito,S. A. Appolonova,E. V. Privalova,Y. N. Belenkov

RATIONAL PHARMACOTHERAPY IN CARDIOLOGYno. 3 (2023): 230-239

引用0浏览0引用

‘Last Mile’ Problem in Remote Patient Monitoring at Home: the Use of Instant Messaging Applications

Elena A. Zheleznykh, Aleksei V. Emelianov,Maria V. Kozhevnikova,Vita Y. Zektser,Elena V. Privalova,Yuri N. Belenkov

2023 Systems and Technologies of the Digital HealthCare (STDH) (2023)

引用0浏览0引用

Neuregulin-1 beta, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients

K. A. Zhbanov,E. Yu. Salakheeva,I. Ya. Sokolova,E. A. Zheleznykh,V. Y. Zektser,E. V. Privalova,Yu. N. Belenkov,A. A. Shchendrygina

Rational Pharmacotherapy in Cardiology（2022）

引用0浏览0引用

Evaluation of Fibrosis Markers as a Potential Method for Diagnosing Non-Obstructive Coronary Artery Disease in Patients with Stable Coronary Artery Disease

N. N. Pakhtusov,A. O. Yusupova,K. A. Zhbanov, A. A. Shchedrygina,E. V. Privalova,Yu. N. Belenkov

RATIONAL PHARMACOTHERAPY IN CARDIOLOGY（2022）

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn